Drug Type Small molecule drug |
Synonyms Naphthalene 2-sulfonate polymer, Naphthalene sulfonate polymer (PRO 2000), Polynaphthalene sulphonate + [6] |
Target |
Mechanism CD4 inhibitors(T-cell surface antigen CD4 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC11H10NaO4S |
InChIKeyIWQLXFICQJMUGN-UHFFFAOYSA-N |
CAS Registry29321-75-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chlamydia Infections | Phase 3 | ZA | 01 Oct 2005 | |
Chlamydia Infections | Phase 3 | TZ | 01 Oct 2005 | |
Chlamydia Infections | Phase 3 | UG | 01 Oct 2005 | |
Chlamydia Infections | Phase 3 | ZM | 01 Oct 2005 | |
Gonorrhea | Phase 3 | ZA | 01 Oct 2005 | |
Gonorrhea | Phase 3 | TZ | 01 Oct 2005 | |
Gonorrhea | Phase 3 | UG | 01 Oct 2005 | |
Gonorrhea | Phase 3 | ZM | 01 Oct 2005 | |
Herpes Genitalis | Phase 3 | ZA | 01 Oct 2005 | |
Herpes Genitalis | Phase 3 | TZ | 01 Oct 2005 |
Not Applicable | 1,146 | ydltpxzppp(ncephzbhgd) = pzjumorjww ylmoweippo (nehsuitjvs ) | - | 01 Jan 2010 | |||
Not Applicable | - | 1,146 | (Participants using condoms) | rvkbqiokjz(bcctryxfrt) = iuzhomjqpi mslmshztao (avgjuqyrfe ) | - | 01 Jan 2010 | |
Not Applicable | - | 42 | rjzishwxlx(iekxmjixqc) = Twenty-four (57%) participants experienced at least one AE judged possibly related to product use, of whom 7 (17%) experienced a moderate AE and 17 (40%) experienced only mild AEs. There were no serious AEs, and no AEs were judged probably or definitely related to product use. krfglpxxkm (hpwcyludmd ) | - | 01 Jan 2005 | ||
Not Applicable | - | ajuqmijqpw(gccdjsoyrb) = gpajoqktey gouxkzqmra (uhyexabkgh ) | - | 01 Jan 2002 | |||
ajuqmijqpw(gccdjsoyrb) = jreiemdiaa gouxkzqmra (uhyexabkgh ) |